News from ptc therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 21, 2015, 16:30 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on August 20, 2015 it approved non-statutory stock options to purchase an aggregate...

Aug 14, 2015, 16:15 ET

PTC Therapeutics Announces Closing of $150 Million of Convertible Senior Notes

 PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the closing of its previously announced private offering of $150 million in aggregate...

Aug 11, 2015, 09:09 ET

PTC Therapeutics Announces Pricing of $125 Million of Convertible Senior Notes

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has priced its private offering of $125 million in aggregate principal amount of its...

Aug 10, 2015, 16:22 ET

PTC Therapeutics Announces Intention to Offer Convertible Senior Notes

 PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it proposes to offer $125 million in aggregate principal amount of its convertible...

Jul 30, 2015, 16:05 ET

PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the second quarter ending June 30,...

Jul 16, 2015, 16:30 ET

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2015 Financial Results

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2015...

Jun 23, 2015, 14:53 ET

PTC Therapeutics' CEO Stuart W. Peltz, Ph.D. Finalist For The 2015 NJBiz Innovation Hero Award

Please replace the press release from June 23rd, 10:30 am ET with the following corrected version. The corrected version reads: PTC Therapeutics'...

Jun 15, 2015, 08:00 ET

PTC Therapeutics Appoints Glenn D. Steele Jr., M.D., Ph.D. to Board of Directors

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Glenn D. Steele Jr., M.D., Ph.D. to the company's Board of Directors. Dr....

Jun 12, 2015, 16:30 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 9, 2015 it approved non-statutory stock options to purchase an aggregate of...

Jun 12, 2015, 08:00 ET

PTC Therapeutics and BioMarin Pharmaceutical to Host DMD Industry Symposium

 PTC Therapeutics, Inc. (NASDAQ: PTCT) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that they will host an Industry Update...

May 21, 2015, 16:01 ET

German Federal Joint Committee Issues Positive Medical Benefit Rating for Translarna™ in Patients with Nonsense Mutation Duchenne Muscular Dystrophy

 PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that the Benefit Assessment by Germany's Federal Joint Committee (G-BA) indicated that...

May 15, 2015, 17:58 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on May 15, 2015 it approved non-statutory stock options to purchase an aggregate of...

May 11, 2015, 08:00 ET
PTC Therapeutics logo.

PTC Therapeutics Launches STRIVE Grant Award Program

SOUTH PLAINFIELD, N.J., May 11, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced it has launched STRIVE (Strategies to...

May 04, 2015, 16:05 ET

PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the first quarter ending March 31,...

Apr 28, 2015, 08:00 ET

PTC Therapeutics' Cancer Stem Cell Program Targeting BMI1 Enters Phase 1

PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that its oncology program targeting BMI1, a protein linked to drug-resistant cancers, has...

Apr 23, 2015, 08:00 ET

PTC Therapeutics to Participate at Upcoming Investor Conferences

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: -...

Apr 20, 2015, 08:02 ET

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2015 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2015...

Apr 20, 2015, 08:00 ET

Phase 1 Data from Spinal Muscular Atrophy Program to be Presented at the 2015 American Academy of Neurology Annual Meeting

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Phase 1 clinical data from the company's joint development program with Roche and...

Apr 10, 2015, 16:31 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 7, 2015 it approved non-statutory stock options to purchase an aggregate of...

Apr 08, 2015, 08:00 ET

PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas

SOUTH PLAINFIELD, N.J., April 8, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced the appointment of Eric Pauwels as...